UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 443

Sortiert nach

Biopsie liquide : cellules tumorales circulantes et radiothérapie

Oncologie (Paris, France), 2017-04, Vol.19 (3-4), p.71-76

2017

Volltextzugriff (PDF)

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Annals of oncology, 2012-03, Vol.23 (3), p.618-624

2012

Volltextzugriff (PDF)

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Annals of oncology, 2018-08, Vol.29 (8), p.1777-1783

2018

Volltextzugriff (PDF)

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Annals of oncology, 2017-08, Vol.28 (8), p.1996-2001

2017

Volltextzugriff (PDF)

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Annals of oncology, 2007-12, Vol.18 (12), p.1927-1934

2007

Volltextzugriff (PDF)

Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study

Breast cancer research and treatment, 2014-11, Vol.148 (2), p.345-353

2014

Volltextzugriff (PDF)

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

Annals of oncology, 2017-09, Vol.28 (9), p.2233-2240

2017

Volltextzugriff (PDF)

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

Annals of oncology, 2010-09, Vol.21 (9), p.1765-1771

2010

Volltextzugriff (PDF)

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

Annals of oncology, 2010-04, Vol.21 (4), p.729-733

2010

Volltextzugriff (PDF)

Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

Breast cancer research and treatment, 2019-12, Vol.178 (3), p.505-512

2019

Volltextzugriff (PDF)

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

Annals of oncology, 2013-08, Vol.24 (8), p.2057-2061

2013

Volltextzugriff (PDF)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Annals of oncology, 2017-01, Vol.28 (1), p.16-33

2017

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

European journal of cancer (1990), 2013-04, Vol.49 (6), p.1236-1245

2013

Volltextzugriff (PDF)

Circulating tumor cells and circulating tumor DNA: what surgical oncologists need to know?

European journal of surgical oncology, 2017-05, Vol.43 (5), p.949-962

2017

Volltextzugriff (PDF)

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Annals of oncology, 2013-05, Vol.24 (5), p.1231-1238

2013

Volltextzugriff (PDF)

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer

Annals of oncology, 2015-01, Vol.26 (1), p.89-94

2015

Volltextzugriff (PDF)

Prolifération des cancers du sein et biomarqueurs décisionnels en pratique RPC (RPC 2013)

Oncologie (Paris), 2013-12, Vol.15 (12), p.594-604

2013

Volltextzugriff (PDF)

Circulating tumor DNA detection in hepatocellular carcinoma

Annals of oncology, 2018-05, Vol.29 (5), p.1094-1096

2018

Volltextzugriff (PDF)

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial

Annals of oncology, 2013-12, Vol.24 (12), p.2999-3004

2013

Volltextzugriff (PDF)

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

Annals of oncology, 2008-03, Vol.19 (3), p.496-500

2008

Volltextzugriff (PDF)

Survival of breast cancer patients with meningeal carcinomatosis

Annals of oncology, 2010-11, Vol.21 (11), p.2183-2187

2010

Volltextzugriff (PDF)

Circulating tumor cell count and thrombosis in metastatic breast cancer

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1981-1988

2017

Volltextzugriff (PDF)

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Oncogene, 2023-06, Vol.42 (23), p.1951-1956

2023

Volltextzugriff (PDF)

The impact of expression profiling on prognostic and predictive testing in breast cancer

Journal of Clinical Pathology, 2006-03, Vol.59 (3), p.225-231

2006

Volltextzugriff (PDF)

1 – 25 von 443

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(434)
Mit Volltextzugriff
(418)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(148)
Science & Technology
(143)
Life Sciences & Biomedicine
(140)
Oncology
(129)
Female
(128)
Middle Aged
(94)
Adult
(86)
Breast Cancer
(82)
Aged
(74)
Breast Neoplasms - Pathology
(66)
Biological And Medical Sciences
(63)
Medical Sciences
(63)
Breast Neoplasms - Drug Therapy
(61)
Tumors
(53)
Prognosis
(49)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(46)
Chemotherapy
(39)
Treatment Outcome
(35)
Pharmacology. Drug Treatments
(32)
Gynecology. Andrology. Obstetrics
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(94)
Annals Of Oncology
(83)
Journal Of Clinical Oncology
(37)
European Journal Of Cancer
(28)
Bulletin Du Cancer
(27)
Cancer Radiothérapie
(26)
British Journal Of Cancer
(16)
International Journal Of Radiation Oncology, Biology, Physics
(10)
Esmo Open
(7)
Breast
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biopsie liquide : cellules tumorales circulantes et radiothérapie

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Circulating tumor cells and circulating tumor DNA: what surgical oncologists need to know?

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer

Prolifération des cancers du sein et biomarqueurs décisionnels en pratique RPC (RPC 2013)

Circulating tumor DNA detection in hepatocellular carcinoma

Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

Survival of breast cancer patients with meningeal carcinomatosis

Circulating tumor cell count and thrombosis in metastatic breast cancer

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

The impact of expression profiling on prognostic and predictive testing in breast cancer

Suchergebnisse filtern